上游刺激因子2通过调节线粒体平衡来保护心肌细胞
Wenbin Wu1, Kexin Zhao1, Kejuan Li1
1Department of Cardiology, Lanzhou University Second Hospital.
International heart journal
|March 30, 2025
概括
上游刺激因子2 (USF2) 保护心脏细胞免受低氧造成的损伤. 失去USF2会恶化线粒体损伤并促进细胞死亡,这表明USF2是治疗心脏病的治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 线粒体医学 线粒体医学
- 分子心脏病学分子心脏病学
背景情况:
- 心肌缺血和缺氧是心力衰竭的主要驱动因素.
- 来自线粒体损伤的心肌细胞亡是不良心脏重塑的基础.
- 转录因子USF2在心血管疾病中的作用以前没有报告.
研究的目的:
- 研究上游刺激因子2 (USF2) 在心肌细胞对低氧反应中的作用.
- 阐明USF2通过哪些机制影响心脏中的线粒体功能和亡.
主要方法:
- 在低氧条件下的心肌细胞中研究了USF2蛋白表达和降解.
- 利用USF2删除模型来评估对线粒体功能和亡的影响.
- 分析了USF2缺乏细胞中AMPK/mTOR信号通路的参与.
主要成果:
- 缺氧诱导USF2蛋白在心肌细胞通过ubiquitin-proteasome路径降解.
- 删除USF2会导致线粒体功能障碍,损伤增加和亡的增强.
- 缺少USF2通过调节AMPK/mTOR信号通路来促进亡.
结论:
- USF2对缺氧心肌细胞损伤起着保护作用.
- 缺乏USF2会加剧线粒体损伤和心脏中的亡.
- USF2代表了肌肉心脏缺氧和相关心力衰竭的潜在治疗标.
更多相关视频
07:14A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
Published on: July 13, 2018
11:26Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
相关概念视频
Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Pathophysiology of Cardiac Performance
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
